Acadia Pharmaceuticals Inc. (ACAD) Stock Price, Quote & AI Analysis
Live ACAD stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Acadia Pharmaceuticals Inc..
TradeVae provides AI-driven analysis and real-time market intelligence for Acadia Pharmaceuticals Inc. (ACAD), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Acadia Pharmaceuticals Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Acadia Pharmaceuticals Inc. Overview
Company information
Company Overview
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Acadia Pharmaceuticals Inc. Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...